2017
DOI: 10.1016/j.cels.2017.07.005
|View full text |Cite
|
Sign up to set email alerts
|

Cell-Cycle Position of Single MYC-Driven Cancer Cells Dictates Their Susceptibility to a Chemotherapeutic Drug

Abstract: While many tumors initially respond to chemotherapy, regrowth of surviving cells compromises treatment efficacy in the long term. The cell-biological basis of this regrowth is not understood. Here, we characterize the response of individual, patient-derived neuroblastoma cells driven by the prominent oncogene MYC to the first-line chemotherapy, doxorubicin. Combining live-cell imaging, cell-cycle-resolved transcriptomics, and mathematical modeling, we demonstrate that a cell's treatment response is dictated by… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

4
39
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
4
2
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 66 publications
(46 citation statements)
references
References 63 publications
4
39
1
Order By: Relevance
“…However, these models do not account for the observed distribution of cell cycle phase durations in single cells nor do they explain how phase durations can be both heritable and independent. Such a systems‐level understanding of the governing principles regulating cell cycle progression could provide a new conceptual framework to guide further experimental work and therapeutic efforts (Ryl et al , ). In this study, we developed a phenomenological model for cell cycle progression informed by precise measurements of G1, S, G2, and M durations in three human cell types.…”
Section: Discussionmentioning
confidence: 99%
“…However, these models do not account for the observed distribution of cell cycle phase durations in single cells nor do they explain how phase durations can be both heritable and independent. Such a systems‐level understanding of the governing principles regulating cell cycle progression could provide a new conceptual framework to guide further experimental work and therapeutic efforts (Ryl et al , ). In this study, we developed a phenomenological model for cell cycle progression informed by precise measurements of G1, S, G2, and M durations in three human cell types.…”
Section: Discussionmentioning
confidence: 99%
“…The ability to monitor single cells in real time has revealed the integral role of the cell cycle in controlling multiple cellular processes including the decision between proliferation or quiescence 19,47,48 , differentiation of pluripotent cells into multiple lineages [49][50][51] , and susceptibility to chemotherapeutics 52 . Therefore, knowledge of the principles underlying cell cycle progression will provide insights into how cell fate decisions are determined and how they can be manipulated for therapeutic gain.…”
Section: Discussionmentioning
confidence: 99%
“…In patient-derived neuroblastoma samples, MYC expression is negatively correlated with the likelihood an individual cell will become senescent in response to doxorubicin treatment (Ryl et al 2017). In cells with high MYC expression that did not senesce, cell fate was governed by cell cycle phase at the time of doxorubicin addition.…”
Section: Cellular Manifestations Of Molecular Heterogeneity Impactingmentioning
confidence: 99%